Authors' reply
- PMID: 38692614
- DOI: 10.25259/NMJI_163_2023
Authors' reply
Comment on
-
Evaluation of satisfaction and reasons for participation in a Covid-19 vaccine clinical trial: A single-centre, observational study.Natl Med J India. 2022 Jul-Aug;35(4):214-218. doi: 10.25259/NMJI_496_22. Natl Med J India. 2022. PMID: 36715046
-
Satisfaction and reasons for participation in a Covid-19 vaccine clinical trial.Natl Med J India. 2023 May-Jun;36(3):204-205. doi: 10.25259/NMJI_98_2023. Natl Med J India. 2023. PMID: 38692618 No abstract available.
References
-
- Kleebaoon A, Mungmunpuntipantip R, Wiwanitkit V,. Satisfaction and reasons for participation in a Covid-19 vaccine clinical trial. Natl Med J India. 2023; 36:204-5
-
- Kulkarni PS, Padmapriyadarsini C, Vekemans J, Bavdekar A, Gupta M, Kulkarni P, et al. A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India. E Clin Med. 2021; 42:101218
-
- Available at https://ycharts.com/indicators/india_coronavirus_full_vaccination_rate (accessed on 24 Feb 2023)
-
- Sallam M,. COVID-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates. Vaccines. 2021; 9:160